Psychiatry and Neurology, Neurology · Ames, IA
NPI
1609867688
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1015 Duff Ave
Ames, IA, 50010
Phone (515) 239-4435
Groups this clinician bills Medicare through
Medicare paid, 2024
$171K
17,718 services
Medicare patients, 2024
408
Average age 68
Drug cost, 2024
$1.5M
4,606 prescriptions
Company payments, 2025
$528
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David B Moore was code J0585 (injection, onabotulinumtoxina, 1 unit), 16,338 times for 39 patients. In total David B Moore billed 17,718 services in 66 codes, and Medicare paid $171K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 16,338 | 39 | $4.85 | $79K |
| 99214 Office E&M - Established | Office | 251 | 183 | $76.30 | $19K |
| J0475 Injection, baclofen, 10 mg | Office | 191 | 13 | $133.47 | $25K |
| 99213 Office E&M - Established | Office | 164 | 145 | $58.96 | $9,669 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 128 | 95 | $10.93 | $1,399 |
| 99212 Office E&M - Established | Office | 109 | 49 | $34.90 | $3,804 |
| 36415 Venipuncture Blood Collection | Office | 50 | 42 | $8.65 | $433 |
| 99215 Office E&M - Established | Office | 48 | 44 | $118.10 | $5,669 |
| 64612 Musculoskeletal | Office | 34 | 13 | $118.87 | $4,042 |
| 95874 Musculoskeletal | Office | 34 | 12 | $53.23 | $1,810 |
| 99205 Office E&M - New | Office | 30 | 30 | $140.41 | $4,212 |
| 62370 Musculoskeletal | Office | 28 | 13 | $56.16 | $1,573 |
| 64615 Musculoskeletal | Office | 24 | 11 | $81.16 | $1,948 |
| 95970 Electrical Nerve Conductivity | Office | 18 | 15 | $10.69 | $192 |
| 95816 Neurologic | Facility | 17 | 17 | $39.12 | $665 |
By year: 2022 $213K for 21,503 services; 2023 $186K for 19,530 services; 2024 $171K for 17,718 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 50 | 42 | $8.65 | $433 |
| 85025 Blood Count | 17 | 17 | $7.61 | $129 |
| 82607 Clinical Chemistry | 15 | 14 | $14.78 | $222 |
| 82746 Clinical Chemistry | 13 | 12 | $14.41 | $187 |
Medicare prescription drug claims, 2024
In 2024, the drug David B Moore prescribed most often to Medicare patients was Lamotrigine, with 501 prescriptions and refills. In total David B Moore wrote 4,606 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 501 | 651 | 60 | $7,645 |
| Levetiracetam Generic | 424 | 684 | 72 | $14K |
| Lacosamide Generic | 408 | 485 | 28 | $54K |
| Divalproex Sodium Er Divalproex Sodium | 242 | 293 | 22 | $24K |
| Clobazam Generic | 172 | 172 | Under 11 | $9,826 |
| Divalproex Sodium Generic | 171 | 185 | 20 | $19K |
| Clonazepam Generic | 145 | 154 | Under 11 | $1,744 |
| Rufinamide Generic | 120 | 125 | Under 11 | $99K |
| Primidone Generic | 103 | 129 | 20 | $2,098 |
| Zonisamide Generic | 103 | 117 | 11 | $2,818 |
| Phenobarbital Generic | 99 | 109 | Under 11 | $626 |
| Baclofen Generic | 94 | 120 | 14 | $3,880 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 93 | 131 | 23 | $3,407 |
| Topiramate Generic | 90 | 150 | 18 | $1,010 |
| Gabapentin Generic | 83 | 117 | 13 | $1,750 |
Brand drugs: 432 claims; generic drugs: 4,075 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David B Moore $528 ($528 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $206.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.